Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stig Linder
Inhibition of Proteasome Deubiquitinase Activity: A Strategy to Overcome Resistance to Conventional Proteasome Inhibitors?
Drug Resistance Updates
Cancer Research
Oncology
Infectious Diseases
Pharmacology
Diagnostic and Prognostic Role of Plasma Levels of Two Forms of Cytokeratin 18 in Patients With Non-Small-Cell Lung Cancer
European Journal of Cancer
Cancer Research
Oncology
Antiproliferative Effects of the Natural Oxadiazine Nocuolin a Are Associated With Impairment of Mitochondrial Oxidative Phosphorylation
Frontiers in Oncology
Cancer Research
Oncology
The Deubiquitinase Inhibitor B-Ap15 Induces Strong Proteotoxic Stress and Mitochondrial Damage
Biochemical Pharmacology
Biochemistry
Pharmacology
Phase 1 Study of the Protein Deubiquitinase Inhibitor VLX1570 in Patients With Relapsed and/or Refractory Multiple Myeloma
Investigational New Drugs
Oncology
Pharmacology
Acute Lymphoblastic Leukemia Cells Are Sensitive to Disturbances in Protein Homeostasis Induced by Proteasome Deubiquitinase Inhibition
Oncotarget
Oncology
Increased Expression of Cathepsin D Is Required for L1-Mediated Colon Cancer Progression
Oncotarget
Oncology
Author Correction: Cytotoxic Unsaturated Electrophilic Compounds Commonly Target the Ubiquitin Proteasome System
Scientific Reports
Multidisciplinary
Differentiation Between Cell Death Modes Using Measurements of Different Soluble Forms of Extracellular Cytokeratin 18
Cancer Research
Cancer Research
Oncology
Identification of a Novel Topoisomerase Inhibitor Effective in Cells Overexpressing Drug Efflux Transporters
PLoS ONE
Multidisciplinary
1
2
›